Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Procter & Gamble | PG | Apr 18, 2024 | 157.29 | +0.21 |
Professional Diversity Network | IPDN | Apr 18, 2024 | 1.68 | -1.75 |
Profire Energy | PFIE | Apr 18, 2024 | 1.85 | +6.32 |
Profound Medical | PROF | Apr 18, 2024 | 7.84 | +0.58 |
ProFrac A | ACDC | Apr 18, 2024 | 7.93 | +5.87 |
PROG | PRG | Apr 18, 2024 | 30.86 | +0.59 |
Progress Software | PRGS | Apr 18, 2024 | 50.19 | -0.79 |
Progressive | PGR | Apr 18, 2024 | 209.75 | +0.30 |
Progyny | PGNY | Apr 18, 2024 | 31.88 | -2.66 |
Project Energy Reimagined Acquisition A | PEGR | Apr 18, 2024 | 9.19 | +0.99 |
Project Energy Reimagined Acquisition Unit | PEGRU | Apr 18, 2024 | 10.91 | 0.00 |
ProKidney | PROK | Apr 18, 2024 | 2.40 | -15.49 |
Prologis | PLD | Apr 18, 2024 | 104.69 | -1.69 |
ProMIS Neurosciences | PMN | Apr 18, 2024 | 2.00 | +7.52 |
PropertyGuru | PGRU | Apr 18, 2024 | 3.65 | -0.55 |
ProPetro | PUMP | Apr 18, 2024 | 8.44 | +3.05 |
ProPhase Labs | PRPH | Apr 18, 2024 | 5.44 | -13.24 |
ProQR Therapeutics | PRQR | Apr 18, 2024 | 1.86 | -2.11 |
PROS | PRO | Apr 18, 2024 | 33.48 | -0.59 |
Proshares Ultra FTSE Europe | UPV | Apr 18, 2024 | 57.64 | -0.56 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Apr 18, 2024 | 73.20 | +0.27 |
Proshares Ultrashort FTSE Europe | EPV | Apr 18, 2024 | 8.51 | +0.47 |
ProSomnus | OSA | Apr 18, 2024 | 0.47 | 0.00 |
Prospect Capital | PSEC | Apr 18, 2024 | 5.47 | +0.92 |
Prospect Capital A Pref | PSEC-A | Apr 18, 2024 | 17.18 | +1.06 |
Prosperity Bancshares | PB | Apr 18, 2024 | 59.69 | +0.51 |
Protagonist Therapeutics | PTGX | Apr 18, 2024 | 25.22 | -1.37 |
Protalix Bio Therapeutics | PLX | Apr 18, 2024 | 1.13 | -1.74 |
Protara Therapeutics | TARA | Apr 18, 2024 | 2.75 | +0.73 |
Prothena | PRTA | Apr 18, 2024 | 20.57 | -2.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.